Cargando…
Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measure()
BACKGROUND: Ordinalised vascular outcomes incorporating event severity are more informative than binary outcomes that just include event numbers. The TARDIS trial was the first vascular prevention study to use an ordinalised vascular outcome as its primary efficacy and safety measures and collected...
Autores principales: | Woodhouse, Lisa J., Montgomery, Alan A., Pocock, Stuart, James, Marilyn, Ranta, Anna, Bath, Philip M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517366/ https://www.ncbi.nlm.nih.gov/pubmed/37745289 http://dx.doi.org/10.1016/j.conctc.2023.101186 |
Ejemplares similares
-
Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
por: Bath, Philip M W, et al.
Publicado: (2015) -
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
por: Bath, Philip M, et al.
Publicado: (2018) -
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials
por: Woodhouse, Lisa J., et al.
Publicado: (2021) -
Data sharing: experience of accessing individual patient data from completed randomised controlled trials in vascular and cognitive medicine
por: Scutt, Polly, et al.
Publicado: (2020) -
A win ratio approach to comparing ordinal or non-normal outcomes in clinical trials
por: Wang, Duolao, et al.
Publicado: (2013)